Blepharitis

Patients with no visual complaints or changes that threaten vision are typically seen 4 to 6 weeks following initial assessment to evaluate treatment response. Follow-up after that depends on progress.

Patients with vision-threatening complications need to be assessed more frequently, depending on severity.